The Uncertain Role of Immunomodulator Maintenance After Cessation of Anti-Tumor Necrosis Factor α Therapy

Clin Gastroenterol Hepatol. 2015 Aug;13(8):1551-2. doi: 10.1016/j.cgh.2015.01.006. Epub 2015 Jan 16.

Authors

Keith Sultan¹, Sumant Inamdar¹, Robert Hirten¹

Affiliation

¹ Division of Gastroenterology, Hofstra North Shore-LIJ School of Medicine, Manhasset, New York.

PMID: 25599656
DOI: 10.1016/j.cgh.2015.01.006

No abstract available

Publication types

Letter
Comment

MeSH terms

Crohn Disease / drug therapy*
Crohn Disease / pathology*
Female
Humans
Immunologic Factors / therapeutic use*
Infliximab / therapeutic use*
Male

Substances

Immunologic Factors
Infliximab